CLINICAL TRIALS PROFILE FOR EDETATE CALCIUM DISODIUM
✉ Email this page to a colleague
All Clinical Trials for EDETATE CALCIUM DISODIUM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00378781 ↗ | Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection | Withdrawn | National Cancer Institute (NCI) | N/A | 1969-12-31 | RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. |
| NCT00378781 ↗ | Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection | Withdrawn | M.D. Anderson Cancer Center | N/A | 1969-12-31 | RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. |
| NCT01101412 ↗ | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | Withdrawn | National Cancer Institute (NCI) | Phase 1/Phase 2 | 1969-12-31 | RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies. |
| NCT01101412 ↗ | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | Withdrawn | M.D. Anderson Cancer Center | Phase 1/Phase 2 | 1969-12-31 | RATIONALE: Antimicrobial solution comprising trimethoprim-sulfamethoxazole, edetate calcium disodium, and ethanol may help prevent blockages and infections from forming in patients with central venous access catheters or peripheral venous catheters. PURPOSE: This randomized trial is studying an antimicrobial solution or saline solution in maintaining catheter patency and preventing catheter-related blood infections in patients with malignancies. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EDETATE CALCIUM DISODIUM
Condition Name
Clinical Trial Locations for EDETATE CALCIUM DISODIUM
Trials by Country
Clinical Trial Progress for EDETATE CALCIUM DISODIUM
Clinical Trial Phase
Clinical Trial Sponsors for EDETATE CALCIUM DISODIUM
Sponsor Name
